News | June 03, 2009

Canadian Isotope Reactor Will be Shut Down for Three Months


June 3, 2009 - The Chalk River Laboratories (CRL) nuclear reactor, which supplies about a third of the world’s medical isotopes, has been shut down since May 14 and is not expected to be back for at least three months, according to Atomic Energy of Canada Ltd. (AECL).

The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which are used in diagnostic nuclear imaging scans.

AECL reported the NRU reactor at Chalk River would remain out of service for more than a month in order to investigate and repair a heavy water leak in the reactor vessel. The location of the heavy water leak has been identified at the base of the reactor vessel in a location where there is corrosion on the outside wall of the vessel.

“Sophisticated diagnostic procedures are required to determine the exact nature and extent of the repairs before returning the NRU reactor safely to service,” said Bill Pilkington, AECL’s senior vice-president and chief nuclear officer. “Based on our preliminary findings to date, we now believe that the NRU reactor will be out of service for at least three months.”

On June 2 AECL said it began the process of removing fuel rods from the NRU reactor as part of the process to repair the reactor and return it to service. There were about 100 rods in the reactor at the time NRU was shut down and officials said it will take an estimated three to four weeks to complete.

For more information: www.aecl.ca


Related Content

News | Radiopharmaceuticals and Tracers

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

Home April 13, 2023
Home
News | Radiopharmaceuticals and Tracers

Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical ...

Home November 05, 2022
Home
News | Radiopharmaceuticals and Tracers

June 24, 2022 — Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive ...

Home June 24, 2022
Home
News | Radiopharmaceuticals and Tracers

August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
News | Radiopharmaceuticals and Tracers

July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot ...

Home July 16, 2019
Home
News | Radiopharmaceuticals and Tracers

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...

Home June 05, 2019
Home
News | Radiopharmaceuticals and Tracers

May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...

Home May 17, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...

Home May 10, 2019
Home
News | Radiopharmaceuticals and Tracers

October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide ...

Home October 12, 2018
Home
Feature | Radiopharmaceuticals and Tracers | Dave Fornell

February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...

Home February 26, 2018
Home
Subscribe Now